INCY: Incyte Corporation

INCY News

• Investing 22:56 Phase 3 Data for Incyte’s Retifanlimab (Zynyz ®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet
• Investing 16:13 Specialised Therapeutics expands oncology portfolio with Incyte deal
• Investing 14:11 Incyte stock holds steady as UBS maintains neutral rating
• Investing 11:36 MacroGenics stock soars on royalty deal with Sagard
• Investing 17:01 Incyte at Goldman Sachs Conference: Growth Beyond Jakafi
• Investing 20:40 Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Investing 13:38 Stifel maintains hold rating on Incyte stock, keeps $75 price target
• Investing 11:19 TD Cowen maintains Buy rating on Incyte stock, sees promising data
• Investing 20:45 JPMorgan maintains neutral rating on Incyte stock amid trial data
• Investing 17:47 Citi maintains buy rating for Incyte stock amid promising trial data
• Investing 16:56 BMO Capital reiterates underperform rating on Incyte stock
• Investing 15:00 Incyte stock rises following EHA presentation acceptance
• Investing 14:37 Incyte reveals promising trial data for essential thrombocythemia treatment
• Investing 14:40 UBS maintains neutral rating on Incyte stock amid drug concerns
• Seeking Alpha 04:20 abrdn Life Sciences Investors Q1 2025 Commentary
• Investing 09:50 Citizens JMP highlights key ASCO presentations
• Seeking Alpha 15:41 Incyte: Good Company, But Potentially Overvalued Given Patent Cliffs (NASDAQ:INCY)
• GuruFocus 18:00 Hedge Funds Crowd Avis, Loar and Howard Hughes
• Investing 18:36 FDA approves new anal cancer treatment Zynyz by Incyte
• Investing 12:02 Incyte settles royalty dispute with Novartis for $280 million
• GuruFocus 09:00 Why Low-Debt Stocks Are the Way to Go
• Benzinga 16:09 Tech Stocks Rebound As US Treasuries Tumble, Gold Eyes Best Gain In Over 2 Years: What's Driving Markets Wednesday? - Apple (NASDAQ:AAPL)
• Seeking Alpha 13:08 Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX)
• Benzinga 08:28 Meta, AMD, Apple, AT&T Among Biggest US Tech Giants That 'May Suffer The Most' As Tariffs Spark Trade Turmoil: Here's Why - Apple (NASDAQ:AAPL), Albemarle (NYSE:ALB)